We provide you with 20 years of free, institutional-grade data for KALV stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of KALV. Explore the full financial landscape of KALV stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-09-11 | 1348911 | KALV | 10-Q | Url |
| 2025-07-10 | 1348911 | KALV | 10-K | Url |
| 2025-03-12 | 1348911 | KALV | 10-Q | Url |
| 2024-12-05 | 1348911 | KALV | 10-Q | Url |
| 2024-09-05 | 1348911 | KALV | 10-Q | Url |
| 2024-07-11 | 1348911 | KALV | 10-K | Url |
| 2024-03-11 | 1348911 | KALV | 10-Q | Url |
| 2023-12-07 | 1348911 | KALV | 10-Q | Url |
| 2023-09-07 | 1348911 | KALV | 10-Q | Url |
| 2023-07-10 | 1348911 | KALV | 10-K | Url |
| 2023-03-09 | 1348911 | KALV | 10-Q | Url |
| 2022-12-08 | 1348911 | KALV | 10-Q | Url |
| 2022-09-08 | 1348911 | KALV | 10-Q | Url |
| 2022-07-07 | 1348911 | KALV | 10-K | Url |
| 2022-03-10 | 1348911 | KALV | 10-Q | Url |
| 2021-12-09 | 1348911 | KALV | 10-Q | Url |
| 2021-09-09 | 1348911 | KALV | 10-Q | Url |
| 2021-07-13 | 1348911 | KALV | 10-K | Url |
| 2021-03-11 | 1348911 | KALV | 10-Q | Url |
| 2020-12-10 | 1348911 | KALV | 10-Q | Url |
| 2020-09-14 | 1348911 | KALV | 10-Q | Url |
| 2020-07-01 | 1348911 | KALV | 10-K | Url |
| 2020-03-10 | 1348911 | KALV | 10-Q | Url |
| 2019-12-03 | 1348911 | KALV | 10-Q | Url |
| 2019-09-09 | 1348911 | KALV | 10-Q | Url |
| 2019-07-16 | 1348911 | KALV | 10-K | Url |
| 2019-03-14 | 1348911 | KALV | 10-Q | Url |
| 2018-12-14 | 1348911 | KALV | 10-Q | Url |
| 2018-09-14 | 1348911 | KALV | 10-Q | Url |
| 2018-07-30 | 1348911 | KALV | 10-K | Url |
| 2018-03-16 | 1348911 | KALV | 10-Q | Url |
| 2017-12-14 | 1348911 | KALV | 10-Q | Url |
| 2017-09-14 | 1348911 | KALV | 10-Q | Url |
| 2017-07-27 | 1348911 | KALV | 10-K | Url |
| 2017-03-16 | 1348911 | KALV | 10-Q | Url |
| 2016-11-08 | 1348911 | KALV | 10-Q | Url |
| 2016-08-12 | 1348911 | KALV | 10-Q | Url |
| 2016-05-12 | 1348911 | KALV | 10-Q | Url |
| 2016-03-30 | 1348911 | KALV | 10-K | Url |
| 2015-11-12 | 1348911 | KALV | 10-Q | Url |
| 2015-08-13 | 1348911 | KALV | 10-Q | Url |
| 2015-05-21 | 1348911 | KALV | 10-Q | Url |
| 2014-12-29 | 1348911 | KALV | S-1 | Url |
KalVista Pharmaceuticals, Inc(NASDAQ:KALV) 
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HA...
Website: http://www.kalvista.com
Founded: 2004
Full Time Employees: 56
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about KALV stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.